An insight into the challenges faced with AAV-based Gene Therapy

Read the full article here in the European Biopharmaceutical Review.

A lack of suitable and widespread reference material in gene therapy is just one of the many obstacles facing laboratories around the world attempting to find treatments for genetic diseases. Dr. Hüseyin Besir and Dr. Dana Holzinger from PROGEN discuss the challenges faced with AAV-based Gene Therapy. 

Read the full article

This article is taken from European Biopharmaceutical Review January 2021, pages 30-32. © Samedan Ltd